Cardiovascular Echocardiography Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Transthoracic Echocardiography, Transesophageal Echocardiography, Stress Echocardiography, and Fetal Echocardiography), Technology (2D Echocardiogram, 3D Echocardiogram, and Doppler), End User (Hospitals, Ambulatory Surgery Centers, and Diagnostic Labs), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
The cardiovascular echocardiography market size is expected to grow from US$ 143.72 billion in 2022 to US$ 200.00 billion by 2030; it is projected to register a CAGR of 4.2% during 2022-2030.
Cardiovascular echocardiography is a test that uses sound waves to create images of the heart. This testing procedure is usually performed on patients with suspected or known heart diseases. The test is painless and reveals the condition of the heart; the image shows the size, shape, chambers, and valves of the heart and their functioning. The cardiovascular echocardiogram can also identify parts of the heart that are not contracting properly. The injuries from the earlier heart attack can be clearly visualized using echocardiographs. The commonly used diagnostic test for detecting cardiac disorders is transthoracic cardiac ultrasound owing to its non-invasive nature. The cardiovascular echocardiography market growth is attributed to the rising burden of cardiovascular diseases and the advantages of echocardiographic devices over other cardiac diagnostic procedures. However, challenges associated with the use of echocardiography devices hinder the growth of the cardiovascular echocardiography market.
Type-Based Insights
Based on technology, the cardiovascular echocardiography market is categorized into 2D echocardiogram, 3D echocardiogram, and Doppler. The 3D echocardiogram segment held a significant cardiovascular echocardiography market share in 2022. The segment is estimated to register the highest CAGR during the forecast period. The 3D echocardiogram captures three-dimensional images of the heart structures and is used to improve image quality and reader confidence and assess structure and functionality. With measurements made while the heart is beating, the real-time images offer a more accurate evaluation of cardiac function. The best course of treatment for a patient with heart disease can be decided with the 3-D echo, which provides improved images of the heart's anatomy. Over the past two decades, advancements in computer and transducer technologies have allowed the development of 3D echocardiography, which provides significant additional clinical information to traditional 2D echocardiography. Compared to 2D echocardiography, 3D echocardiography offers numerous benefits, such as better quantitation of cardiac volumes, mass, and function, better display and assessment of valve dysfunction; and shorter image acquisition times. It also allows for improved visualization of complex shapes and spatial relations between cardiac structures, which positively influences the growth of the cardiovascular echocardiography market.
Indication-Based Insights
Based on end user, the cardiovascular echocardiography market is segmented into hospitals, ambulatory surgery centers, and diagnostic labs. The hospitals segment held a significant market share in 2022 and is expected to register the highest CAGR during 2022–2030.
The US Food and Drug Administration, the World Health Organization, and the Centers for Disease Control and Prevention are among the primary and secondary sources referred to while preparing the cardiovascular echocardiography market report.
Cardiovascular echocardiography is a test that uses sound waves to create images of the heart. This testing procedure is usually performed on patients with suspected or known heart diseases. The test is painless and reveals the condition of the heart; the image shows the size, shape, chambers, and valves of the heart and their functioning. The cardiovascular echocardiogram can also identify parts of the heart that are not contracting properly. The injuries from the earlier heart attack can be clearly visualized using echocardiographs. The commonly used diagnostic test for detecting cardiac disorders is transthoracic cardiac ultrasound owing to its non-invasive nature. The cardiovascular echocardiography market growth is attributed to the rising burden of cardiovascular diseases and the advantages of echocardiographic devices over other cardiac diagnostic procedures. However, challenges associated with the use of echocardiography devices hinder the growth of the cardiovascular echocardiography market.
Type-Based Insights
Based on technology, the cardiovascular echocardiography market is categorized into 2D echocardiogram, 3D echocardiogram, and Doppler. The 3D echocardiogram segment held a significant cardiovascular echocardiography market share in 2022. The segment is estimated to register the highest CAGR during the forecast period. The 3D echocardiogram captures three-dimensional images of the heart structures and is used to improve image quality and reader confidence and assess structure and functionality. With measurements made while the heart is beating, the real-time images offer a more accurate evaluation of cardiac function. The best course of treatment for a patient with heart disease can be decided with the 3-D echo, which provides improved images of the heart's anatomy. Over the past two decades, advancements in computer and transducer technologies have allowed the development of 3D echocardiography, which provides significant additional clinical information to traditional 2D echocardiography. Compared to 2D echocardiography, 3D echocardiography offers numerous benefits, such as better quantitation of cardiac volumes, mass, and function, better display and assessment of valve dysfunction; and shorter image acquisition times. It also allows for improved visualization of complex shapes and spatial relations between cardiac structures, which positively influences the growth of the cardiovascular echocardiography market.
Indication-Based Insights
Based on end user, the cardiovascular echocardiography market is segmented into hospitals, ambulatory surgery centers, and diagnostic labs. The hospitals segment held a significant market share in 2022 and is expected to register the highest CAGR during 2022–2030.
The US Food and Drug Administration, the World Health Organization, and the Centers for Disease Control and Prevention are among the primary and secondary sources referred to while preparing the cardiovascular echocardiography market report.
1. INTRODUCTION
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. RESEARCH METHODOLOGY
4. CARDIOVASCULAR ECHOCARDIOGRAPHY MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. CARDIOVASCULAR ECHOCARDIOGRAPHY MARKET - KEY MARKET DYNAMICS
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. CARDIOVASCULAR ECHOCARDIOGRAPHY MARKET - GLOBAL MARKET ANALYSIS
6.1 Cardiovascular Echocardiography - Global Market Overview
6.2 Cardiovascular Echocardiography - Global Market and Forecast to 2031
7. CARDIOVASCULAR ECHOCARDIOGRAPHY MARKET – REVENUE ANALYSIS (USD MILLION) – BY TYPE, 2021-2031
7.1 Overview
7.2 Transthoracic Echocardiography
7.3 Transesophageal Echocardiography
7.4 Stress Echocardiography
7.5 Fetal Echocardiography
8. CARDIOVASCULAR ECHOCARDIOGRAPHY MARKET – REVENUE ANALYSIS (USD MILLION) – BY TECHNOLOGY, 2021-2031
8.1 Overview
8.2 2D echocardiogram
8.3 3D echocardiogram
8.4 Doppler
9. CARDIOVASCULAR ECHOCARDIOGRAPHY MARKET – REVENUE ANALYSIS (USD MILLION) – BY END USER, 2021-2031
9.1 Overview
9.2 Hospitals
9.3 Ambulatory Surgery Centers
9.4 Diagnostic Labs
10. CARDIOVASCULAR ECHOCARDIOGRAPHY MARKET - REVENUE ANALYSIS (USD MILLION), 2021-2031 – GEOGRAPHICAL ANALYSIS
10.1 North America
10.1.1 North America Cardiovascular Echocardiography Market Overview
10.1.2 North America Cardiovascular Echocardiography Market Revenue and Forecasts to 2031
10.1.3 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Type
10.1.4 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Technology
10.1.5 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By End User
10.1.6 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Countries
10.1.6.1 United States Cardiovascular Echocardiography Market
10.1.6.1.1 United States Cardiovascular Echocardiography Market, by Type
10.1.6.1.2 United States Cardiovascular Echocardiography Market, by Technology
10.1.6.1.3 United States Cardiovascular Echocardiography Market, by End User
10.1.6.2 Canada Cardiovascular Echocardiography Market
10.1.6.2.1 Canada Cardiovascular Echocardiography Market, by Type
10.1.6.2.2 Canada Cardiovascular Echocardiography Market, by Technology
10.1.6.2.3 Canada Cardiovascular Echocardiography Market, by End User
10.1.6.3 Mexico Cardiovascular Echocardiography Market
10.1.6.3.1 Mexico Cardiovascular Echocardiography Market, by Type
10.1.6.3.2 Mexico Cardiovascular Echocardiography Market, by Technology
10.1.6.3.3 Mexico Cardiovascular Echocardiography Market, by End User
Note - Similar analysis would be provided for below mentioned regions/countries
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Rest of Europe
10.3 Asia-Pacific
10.3.1 Australia
10.3.2 China
10.3.3 India
10.3.4 Japan
10.3.5 South Korea
10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
10.4.1 South Africa
10.4.2 Saudi Arabia
10.4.3 U.A.E
10.4.4 Rest of Middle East and Africa
10.5 South and Central America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Rest of South and Central America
11. INDUSTRY LANDSCAPE
11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments
12. COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration
13. CARDIOVASCULAR ECHOCARDIOGRAPHY MARKET - KEY COMPANY PROFILES
13.1 Apex Heart and Vascular
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
Note - Similar information would be provided for below list of companies
13.2 Ultra-X Imaging
13.3 Metropolitan Heart Vascular Institute
13.4 Ultromics Limited
13.5 Corewell Health
13.6 Centinela Hospital Medical Center
13.7 Schoolcraft Memorial Hospital
13.8 University of Utah Health
13.9 Goshen Heart and Vascular Center
13.10 Harefield Hospital
14. APPENDIX
14.1 Glossary
14.2 About The Insight Partners
14.3 Market Intelligence Cloud
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. RESEARCH METHODOLOGY
4. CARDIOVASCULAR ECHOCARDIOGRAPHY MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. CARDIOVASCULAR ECHOCARDIOGRAPHY MARKET - KEY MARKET DYNAMICS
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. CARDIOVASCULAR ECHOCARDIOGRAPHY MARKET - GLOBAL MARKET ANALYSIS
6.1 Cardiovascular Echocardiography - Global Market Overview
6.2 Cardiovascular Echocardiography - Global Market and Forecast to 2031
7. CARDIOVASCULAR ECHOCARDIOGRAPHY MARKET – REVENUE ANALYSIS (USD MILLION) – BY TYPE, 2021-2031
7.1 Overview
7.2 Transthoracic Echocardiography
7.3 Transesophageal Echocardiography
7.4 Stress Echocardiography
7.5 Fetal Echocardiography
8. CARDIOVASCULAR ECHOCARDIOGRAPHY MARKET – REVENUE ANALYSIS (USD MILLION) – BY TECHNOLOGY, 2021-2031
8.1 Overview
8.2 2D echocardiogram
8.3 3D echocardiogram
8.4 Doppler
9. CARDIOVASCULAR ECHOCARDIOGRAPHY MARKET – REVENUE ANALYSIS (USD MILLION) – BY END USER, 2021-2031
9.1 Overview
9.2 Hospitals
9.3 Ambulatory Surgery Centers
9.4 Diagnostic Labs
10. CARDIOVASCULAR ECHOCARDIOGRAPHY MARKET - REVENUE ANALYSIS (USD MILLION), 2021-2031 – GEOGRAPHICAL ANALYSIS
10.1 North America
10.1.1 North America Cardiovascular Echocardiography Market Overview
10.1.2 North America Cardiovascular Echocardiography Market Revenue and Forecasts to 2031
10.1.3 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Type
10.1.4 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Technology
10.1.5 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By End User
10.1.6 North America Cardiovascular Echocardiography Market Revenue and Forecasts and Analysis - By Countries
10.1.6.1 United States Cardiovascular Echocardiography Market
10.1.6.1.1 United States Cardiovascular Echocardiography Market, by Type
10.1.6.1.2 United States Cardiovascular Echocardiography Market, by Technology
10.1.6.1.3 United States Cardiovascular Echocardiography Market, by End User
10.1.6.2 Canada Cardiovascular Echocardiography Market
10.1.6.2.1 Canada Cardiovascular Echocardiography Market, by Type
10.1.6.2.2 Canada Cardiovascular Echocardiography Market, by Technology
10.1.6.2.3 Canada Cardiovascular Echocardiography Market, by End User
10.1.6.3 Mexico Cardiovascular Echocardiography Market
10.1.6.3.1 Mexico Cardiovascular Echocardiography Market, by Type
10.1.6.3.2 Mexico Cardiovascular Echocardiography Market, by Technology
10.1.6.3.3 Mexico Cardiovascular Echocardiography Market, by End User
Note - Similar analysis would be provided for below mentioned regions/countries
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Rest of Europe
10.3 Asia-Pacific
10.3.1 Australia
10.3.2 China
10.3.3 India
10.3.4 Japan
10.3.5 South Korea
10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
10.4.1 South Africa
10.4.2 Saudi Arabia
10.4.3 U.A.E
10.4.4 Rest of Middle East and Africa
10.5 South and Central America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Rest of South and Central America
11. INDUSTRY LANDSCAPE
11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments
12. COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration
13. CARDIOVASCULAR ECHOCARDIOGRAPHY MARKET - KEY COMPANY PROFILES
13.1 Apex Heart and Vascular
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
Note - Similar information would be provided for below list of companies
13.2 Ultra-X Imaging
13.3 Metropolitan Heart Vascular Institute
13.4 Ultromics Limited
13.5 Corewell Health
13.6 Centinela Hospital Medical Center
13.7 Schoolcraft Memorial Hospital
13.8 University of Utah Health
13.9 Goshen Heart and Vascular Center
13.10 Harefield Hospital
14. APPENDIX
14.1 Glossary
14.2 About The Insight Partners
14.3 Market Intelligence Cloud
